Avinger (NASDAQ:AVGR) Coverage Initiated at StockNews.com

StockNews.com started coverage on shares of Avinger (NASDAQ:AVGRFree Report) in a report issued on Saturday morning. The firm issued a hold rating on the medical device company’s stock.

Avinger Price Performance

NASDAQ:AVGR opened at $0.47 on Friday. The company has a fifty day simple moving average of $0.64 and a two-hundred day simple moving average of $0.85. The company has a market cap of $1.57 million, a price-to-earnings ratio of -0.04 and a beta of 1.09. Avinger has a 52 week low of $0.36 and a 52 week high of $5.45.

About Avinger

(Get Free Report)

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.

Featured Articles

Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.